GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
R

Runben Biotechnology Co 603193.SS · CNY

Consumer Staples · Shanghai · 🇨🇳 China

Compare

17.08

-1.90%

Close of 9 Nov 2026, in CNY

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CNY, from our data supplier.

FY2025

Revenue

CN¥1.54bn

FY2019FY2025

Net income

CN¥314.5m

FY2019FY2025

Free cash flow

CN¥187.4m

FY2019FY2025

Shareholders' equity

CN¥2.22bn

FY2019FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
RevenueCN¥1.54bnCN¥1.32bnCN¥1.03bnCN¥856.1mCN¥582.1mCN¥442.8mCN¥278.6m
Gross profitCN¥900.8mCN¥765.0mCN¥579.6mCN¥462.8mCN¥306.4mCN¥231.8mCN¥148.9m
Research and developmentCN¥37.6mCN¥35.1mCN¥25.7mCN¥19.5mCN¥13.6mCN¥10.7mCN¥7.8m
Operating incomeCN¥333.9mCN¥347.1mCN¥264.6mCN¥185.8mCN¥140.9mCN¥110.2mCN¥41.7m
Net incomeCN¥314.5mCN¥300.2mCN¥226.0mCN¥160.0mCN¥120.6mCN¥94.7mCN¥35.7m
Diluted earnings per share0.800.750.580.490.310.240.09

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Total assetsCN¥2.34bnCN¥2.22bnCN¥2.02bnCN¥825.4mCN¥646.3mCN¥276.5mCN¥164.4m
Cash and short-term investments—CN¥1.36bnCN¥262.8mCN¥376.5mCN¥262.4mCN¥81.7mCN¥35.4m
Total liabilitiesCN¥116.8mCN¥138.9mCN¥97.6mCN¥102.8mCN¥84.7mCN¥26.3mCN¥27.1m
Debt—CN¥1.4mCN¥2.0mCN¥7.9mCN¥10.3m——
Shareholders' equityCN¥2.22bnCN¥2.08bnCN¥1.92bnCN¥722.6mCN¥561.6mCN¥250.1mCN¥137.4m
Shares outstanding394m400m390m324m394m394m394m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Cash from operationsCN¥275.3mCN¥257.2mCN¥252.5mCN¥165.3mCN¥138.7mCN¥87.1mCN¥61.9m
Capital spending−CN¥87.8m−CN¥74.2m−CN¥13.7m−CN¥40.7m−CN¥152.0m−CN¥58.2m−CN¥18.5m
Free cash flowCN¥187.4mCN¥183.0mCN¥238.9mCN¥124.7m−CN¥13.4mCN¥28.9mCN¥43.4m
Dividends paid−CN¥176.2m−CN¥136.0m—−CN¥3.4m−CN¥31.0m——

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueCN¥786.8mCN¥267.1mCN¥307.3mCN¥342.4mCN¥655.1mCN¥240.0mCN¥280.7mCN¥293.5m
Gross profitCN¥480.0mCN¥157.8mCN¥179.6mCN¥204.2mCN¥378.5mCN¥138.4mCN¥159.7mCN¥173.1m
Operating incomeCN¥201.7mCN¥52.1mCN¥39.7mCN¥93.5mCN¥169.8mCN¥50.5mCN¥48.5mCN¥93.6m
Net incomeCN¥172.5mCN¥52.6mCN¥48.5mCN¥78.5mCN¥143.3mCN¥44.2mCN¥39.3mCN¥80.9m
Diluted earnings per share0.440.130.120.200.360.110.100.20
Cash from operations———CN¥91.0mCN¥148.0m−CN¥14.0m—CN¥40.0m
Capital spending−CN¥16.0m−CN¥39.0m−CN¥13.0m−CN¥12.0m−CN¥50.0m−CN¥11.0m−CN¥28.0m−CN¥37.0m
Free cash flow———CN¥79.0mCN¥98.0m−CN¥25.0m—CN¥3.0m
Total assetsCN¥2.55bnCN¥2.43bnCN¥2.34bnCN¥2.31bnCN¥2.34bnCN¥2.30bnCN¥2.22bnCN¥2.22bn
Cash and short-term investments———CN¥1.13bnCN¥1.10bnCN¥1.39bnCN¥1.36bnCN¥396.3m
Debt———CN¥1.4mCN¥1.4mCN¥1.4m——
Shareholders' equityCN¥2.34bnCN¥2.27bnCN¥2.22bnCN¥2.17bnCN¥2.17bnCN¥2.12bnCN¥2.08bnCN¥2.04bn

Financial ratios

Data as of 8 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Gross margin58.3%58.0%56.1%54.1%52.6%52.4%
Operating margin23.5%26.7%26.0%22.1%24.6%24.9%
Net margin20.4%22.8%21.9%18.7%20.7%21.4%
Return on equity14.2%14.4%11.8%22.1%21.5%37.9%
Return on assets13.5%13.5%11.2%19.4%18.7%34.3%
Free cash flow yield4.7%4.3%3.5%3.3%——
Revenue growth17.2%27.6%20.7%47.1%31.5%58.9%
Earnings growth4.8%32.8%41.2%32.7%27.4%165.5%
Current ratio14.53x11.63x18.04x5.28x4.56x5.85x
Debt to equity—0.00x————
Equity ratio95.0%93.7%95.2%87.5%86.9%90.5%
Interest coverage4458.67x2676.43x759.00x152.60x242.29x3187.63x
R&D as a share of sales2.4%2.7%2.5%2.3%2.3%2.4%
Buybacks as a share of market value1.4%-2.6%-20.2%———

Growth per year

Compound annual rate

3 years5 years10 years
Revenue21.7%28.4%—
Operating income21.6%24.8%—
Net income25.3%27.1%—

Average margins

Over each period

1 year3 years5 years10 years
Gross margin58.2%57.0%56.2%—
Operating margin23.8%23.8%23.9%—
Net margin21.5%21.1%21.1%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023
Price to earnings30.431.131.3
Price to sales6.27.16.9

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 29 May 2026.

FY2026FY2025FY2024
Paid in the year0.260.430.35

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.